EUVIMEDEUVIMED entdecken
Crossref

Doxorubicin extravasation: Case series

María L. Melina, Antonella Milano Gil, Patricia C. Patricia C. Docampo

The Poison · 2025

DOI: 10.62129/ykkz6693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Poison, 2025. Verfasst von María L. Melina und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the most severe complications arising from the IV administration of certain cytostatic drugs is the extravasation into adjacent tissue, which causes local irritation, tissue necrosis, and may even result in amputation of the affected limb. According to the literature, the incidence of extravasations in peripheral intravenous administration ranges from 0.1 to 6%. Clinical cases. Three patients presented suffering from doxorubicin extravasation while undergoing chemotherapy treatment. General measures were applied in all cases, and in one case dimethyl sulfoxide (DMSO) was applied topically as an antidote for 24-48 hrs. All three had favorable responses.

Conclusions

Extravasation is a potentially serious complication of doxorubicin infusion. It is key to adhere to safe chemotherapy administration guidelines in order to prevent issues, as well as to continuously train staff.

Zitieren

APA

Melina, M. L., Gil, A. M., & Docampo, P. C. P. C. (2025). Doxorubicin extravasation: Case series. The Poison. https://doi.org/10.62129/ykkz6693

Vancouver

Melina ML, Gil AM, Docampo PCPC. Doxorubicin extravasation: Case series. The Poison. 2025. doi:10.62129/ykkz6693

BibTeX
@article{Melina2025,
  author = {Melina, María L. and Gil, Antonella Milano and Docampo, Patricia C. Patricia C.},
  title = {Doxorubicin extravasation: Case series},
  journal = {The Poison},
  year = {2025},
  doi = {10.62129/ykkz6693}
}
Kostenlos starten →